University of Cambridge

QKine

QKine spun-out from the  University of Cambridge in 2016. The company manufactures high quality growth factors and cytokines for stem cell, organoid and regenerative medicine applications.

QKine uses proprietary protein purification and engineering technology to make recombinant proteins in E.coli. 

 

PolyProx

PolyProx Therapeutics is a spin out of the Department of Pharmacology at the University of Cambridge,  and is based on over a decade of research and intellectual property from Founder, Professor Laura Itzhaki’s laboratory. Professor Itzhaki is joined at PolyProx Therapeutics by serial Cambridge biotech entrepreneurs Kevin Moulder as Chief Operating Officer and Andrew […]

Petmedix

PetMedix is applying 30 years of antibody research to develop new pet therapeutics against a wide range of diseases.

Antibody therapeutics have been transformative in human medicine, treating a wide range of diseases including cancers, autoimmune diseases, and inflammatory conditions. The companion animal therapeutics market represents a $14bn opportunity, and one that is already embracing […]

Flusso

Estblished by the team behind the hugely successful Cambridge CMOS Sensors, Flusso is a new spin-out from the High Voltage Microelectronics and Sensors lab at the University of Cambridge Engineering Department.

The Flusso flow sensor uses a thin hot tungsten wire embedded in a CMOS wafer to measure the flow rate of a range of […]

Echion

Echion Technologies provides a unique platform for battery material and composite manufacture.

Echion’s materials “drop-in” to existing battery manufacturing infrastructure with no capital cost, providing a low barrier to market entry and rapid customer access for their battery materials.

Echion’s technology is safe, high-energy, sustainable and cost effective.

AudioTelligence

AudioTelligence delivers real-time audio processing technology for the enhancement of Automatic Speech Recognition (ASR) systems.

AudioTelligence’s technology dramatically enhances the accuracy of ASR systems, such as those used in mobile devices, home assistants and voice-activated, hands-free automotive systems. It processes the output from low-cost uncalibrated microphones and delivers significant improvements in separating a speaker’s voice […]

Ikarovec

In August 2018 Ikarovek was formed to commercialise certain orphan assets from Quethera, a spin-out from the University of Cambridge, which was acquired by Astellas Pharma Inc.

Initially Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

Sorex Sensors

Sorex Sensors is a spin‐out from the Department of Electrical Engineering at the University of Cambridge.

The company has developed a dual-mode film bulk acoustic resonator (FBAR) sensor technology.

The devices, fabricated on a silicon wafer, comprise a thin film of piezoelectric material that is made to resonate. Attachment of mass to the surface changes the resonant […]

NeoPhore

NeoPhore is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. NeoPhore’s drug target rationale is highly validated by genetic evidence in cancer patients and cellular models.
NeoPhore was created to exploit the first of the pipeline of selective, patient-specific drugs generated by the PhoreMost […]

Paragraf

The Parkwalk Opportunities Fund and the Parkwalk-managed University of Cambridge Enterprise Fund V have invested in a £2.64m seed round in Paragraf Limited, a spin-out from the Department of Materials Science at the University of Cambridge.

Paragraf focuses on the production of ‘two-dimensional’ materials, primarily graphene, and the development of devices based on these materials. Using […]

Predictimmune

We are delighted to announce that the University of Cambridge Enterprise Fund IV and the Parkwalk Opportunities Fund have closed an investment in Predictimmune Limited, a spinout company from the University of Cambridge. Predictimmune is developing prognostic tests for immune-mediated conditions to aid their management and improve patient outcomes.

Their first offering, PredictImmune-CD, will be […]

Focal Point Positioning

The University of Cambridge Enterprise Fund IV has invested in Focal Point Positioning Limited, a spin-out from the University of Cambridge.
Focal Point has developed software which offers highly accurate positioning of smartphones both indoors and outdoors in urban areas.
The company was founded in June 2015 with Dr Ramsey Faragher as CEO and CTO. The team […]

Polypharmakos

Cambridge and Kew join forces to find new antimicrobial substances in plants
The Parkwalk-managed University of Cambridge Enterprise Fund IV and Cambridge Enterprise have invested £500k in Polypharmakos Limited, a spin-out from the University of Cambridge and the Royal Botanic Gardens, Kew.
Polypharmakos’s mission is to screen natural-product sources of plant, fungal and insect origin for […]

Healthera

Healthera Ltd, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals. The specific amounts are undisclosed.

This round of institutional funding allows Healthera to complete its product development on the next generation […]

PervasID

PervasID  is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard.

Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.

PsyOmics

PsyOmics  is a University of Cambridge spin-out working to improve the prevention, diagnosis and treatment of neuropsychiatric disorders.

Mental illness accounts for over 15% of the disease burden in developed countries and in England alone, mental illness costs over £51.6bn per annum.

PsyOmics aims to deliver blood based biomarker diagnostics to:

Rapidly diagnose key mental health disorders
[…]

8Power

8Power is a University of Cambridge start-up developing novel technology for sensing and measurement in industrial applications.

The University of Cambridge is a world leader in the science and technology of sensing, and is pioneering the research of new sensor technologies applied to condition monitoring of built infrastructure and machinery through the Cambridge Centre for Smart […]

Cambridge Touch Technologies

Cambridge Touch Technologies (CTT) is a University of Cambridge start-up developing next-gen 3D touch technology.

CTT’s next generation 3D touch technology enables mobile devices to sense both the location and force of multi-touch inputs. CTT’s technology improves on the first generation of 3D technologies recently introduced to mass markets, which allow users to press a […]

Silicon Microgrvity

Spun-out of the University of Cambridge Nanoscience Centre, Silicon Microgravity is commercialising a sensor technology which provides a breakthrough in the management of oil and gas reservoirs.

The company’s breakthrough sensing technology combines the recording of gravity data at very high sensitivities and seismic data at low frequencies. Both sensing methodologies provide an improved means for […]

GeoSpock

GeoSpock, a spin-out from the University of Cambridge, provides a real-time scaleable database for rapidly changing complex data.  The company’s ambition is to become the Google Search of Big Data.

GeoSpock’s technology platform sits at the base of an infinite number of Industry verticals which require real-time analysis of Big Data and all that confers in […]